Literature DB >> 7356686

Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet.

D Valle, M Walser, S W Brusilow, M Kaiser-Kupfer.   

Abstract

Four patients with gyrate atrophy of the choroid and retina were studied, all of whom exhibited the hyperornithinemia characteristic of this disorder. Elevated plasma histidine and diminished plasma lysine and branched-chain amino acids were also noted. The renal clearances of these four amino acids were not sufficiently elevated to explain their low plasma levels. In one subject, an arginine-deficient diet led to progressive reduction in plasma ornithine from 13 times normal to the upper limits of normal, along with the disappearance of ornithinuria and lysinuria. Orally administered alpha-aminoisobutyric acid facilitated the fall in plasma ornithine by increasing renal losses of ornithine. It also increased the clearances of most other amino acids. When plasma ornithine approached normal (less than 200 microM), plasma lysine became normal, plasma arginine became subnormal, and renal clearances of basic amino acids decreased. Long-term (1.5 yr) maintenance with a diet containing 10-20 g of protein plus essential amino acids served to keep plasma ornithine at between 55-355 microM; chorioretinal degeneration did not progress and vision apparently improved.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356686      PMCID: PMC371375          DOI: 10.1172/JCI109680

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  PURIFICATION AND PROPERTIES OF RAT LIVER ORNITHINE DELTA-TRANSAMINASE.

Authors:  H J STRECKER
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  The amino acid requirements of man. V. The rôle of lysine, arginine, and tryptophan.

Authors:  W C ROSE; W J HAINES; D T WARNER
Journal:  J Biol Chem       Date:  1954-01       Impact factor: 5.157

3.  Nitrogen metabolism in neonatal citrullinaemia.

Authors:  M Walser; M Batshaw; G Sherwood; B Robinson; S Brusilow
Journal:  Clin Sci Mol Med       Date:  1977-08

4.  Raised plasma-ornithine and gyrate atrophy of the choroid and retina.

Authors:  O Simell; K Takki
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

5.  Effects of non-metabolizable analogs on the distribution of amino acids in the rat.

Authors:  H N Christensen; A M Cullen
Journal:  Biochim Biophys Acta       Date:  1968-03-01

6.  A specific enzyme defect in gyrate atrophy.

Authors:  M I Kaiser-Kupfer; D Valle; L A Del Valle
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

7.  Ornithine synthesis from glutamate in rat intestinal mucosa homogenates: evidence for the reduction of glutamate to gamma-glutamyl semialdehyde.

Authors:  G Ross; D Dunn; M E Jones
Journal:  Biochem Biophys Res Commun       Date:  1978-11-14       Impact factor: 3.575

8.  Plasma amino-acids in hereditary retinal disease. Ornithine, lysine, and taurine.

Authors:  E L Berson; S Y Schmidt; A R Rabin
Journal:  Br J Ophthalmol       Date:  1976-02       Impact factor: 4.638

9.  Hyperornithinemia and gyrate atrophy of the choroid and retina.

Authors:  J C McCulloch; S A Arshinoff; E B Marliss; J A Parker
Journal:  Ophthalmology       Date:  1978-09       Impact factor: 12.079

10.  Renal handling of diamino acids in lysinuric protein intolerance.

Authors:  O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  15 in total

1.  Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina.

Authors:  T Wang; G Steel; A H Milam; D Valle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Progression of gyrate atrophy measured with ultra-wide-field imaging.

Authors:  Guillermo Salcedo-Villanueva; Miguel Paciuc-Beja; Cristina Villanueva-Mendoza; Mariana Harasawa; Jesse M Smith; Raul Velez-Montoya; Jeffrey L Olson; Scott C Oliver; Naresh Mandava; Hugo Quiroz-Mercado
Journal:  Int Ophthalmol       Date:  2015-05-26       Impact factor: 2.031

3.  OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retina.

Authors:  Satoshi Katagiri; Tamaki Gekka; Takaaki Hayashi; Hiroyuki Ida; Toya Ohashi; Yoshikatsu Eto; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2014-01-16       Impact factor: 2.379

Review 4.  The eye and inherited metabolic disease: a review.

Authors:  A Michalski; J V Leonard; D S Taylor
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

5.  Treatment of gyrate atrophy of the choroid and retina with low arginine diet.

Authors:  R R McInnes; S A Arshinoff; L Bell; C McCulloch
Journal:  Trans Am Ophthalmol Soc       Date:  1980

6.  A mouse model of gyrate atrophy of the choroid and retina. Early retinal pigment epithelium damage and progressive retinal degeneration.

Authors:  T Wang; A H Milam; G Steel; D Valle
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

7.  Decreased transport of ornithine across the inner mitochondrial membrane as a cause of hyperornithinaemia.

Authors:  F A Hommes; C K Ho; R A Roesel; M E Coryell; B A Gordon
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

8.  Biochemical and therapeutical studies in a case of atrophia gyrata.

Authors:  W Behrens-Baumann; U König; K Schröder; I Hansmann; U Langenbeck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

Review 9.  Retinitis pigmentosa and allied diseases: applications of electroretinographic testing.

Authors:  E L Berson
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

Review 10.  Gyrate atrophy of the choroid and retina. Approaches to therapy.

Authors:  R G Weleber; N G Kennaway; N R Buist
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.